Literature DB >> 6234313

Different conformational states of the purified Ca2+-ATPase of the erythrocyte plasma membrane revealed by controlled trypsin proteolysis.

G Benaim, M Zurini, E Carafoli.   

Abstract

The purified Ca2+-pumping ATPase of the erythrocyte membrane has been exposed to trypsin at 37 degrees C, in the presence of different effectors of its activity. The control proteolytic pattern is characterized by a number of transient and of limit polypeptides (Zurini, M., Krebs, J., Penniston, J. T., and Carafoli, E. (1984) J. Biol. Chem. 259, 618-627). The effectors influence the pattern in the Mr region 90,000-76,000, which contains the calmodulin binding domain and the active site of the enzyme. In this region, polypeptides of 90, 85, 81, and 76 kDa are clearly visible in the controls. 1) Calmodulin plus Ca2+ induces the faster disappearance of the 90-kDa product and the relative accumulation of the 85-kDa with respect to the 81-kDa polypeptide. 2) Vanadate plus Mg2+ also accelerates the disappearance of the 90-kDa product. However, they induce the relative accumulation of the 81-kDa polypeptide. 3) Linoleic acid, which stimulates the activity of the enzyme to the same levels obtained with calmodulin, greatly accelerates the rate of trypsin proteolysis, causing the virtual disappearance of all polypeptides in the 90-76-kDa region. 4) The 81-kDa polypeptide has maximal ATPase activity and is insensitive to calmodulin; the 85-kDa polypeptide has lower ATPase activity and binds calmodulin, but is not stimulated (or is stimulated only negligibly) by the activator.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6234313

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Chlorpromazine and dimethyl sulfoxide modulate the catalytic activity of the plasma membrane Ca2+-ATPase from human erythrocyte.

Authors:  Fernando Plenge-Tellechea; Carlos A Domínguez-Solís; Ángel G Díaz-Sánchez; David Meléndez-Martínez; Javier Vargas-Medrano; Jorge A Sierra-Fonseca
Journal:  J Bioenerg Biomembr       Date:  2018-01-08       Impact factor: 2.945

2.  Structure--function relationship of the human erythrocyte plasma membrane Ca(2+)-ATPase revealed by V8 protease treatment.

Authors:  K K Wang; B D Roufogalis; T H Kuo
Journal:  Biochem J       Date:  1991-10-15       Impact factor: 3.857

Review 3.  Recent advances in the molecular characterization of plasma membrane Ca2+ pumps.

Authors:  E E Strehler
Journal:  J Membr Biol       Date:  1991-02       Impact factor: 1.843

Review 4.  Subunit assembly and functional maturation of Na,K-ATPase.

Authors:  K Geering
Journal:  J Membr Biol       Date:  1990-05       Impact factor: 1.843

5.  Ceramide and sphingosine have an antagonistic effect on the plasma-membrane Ca2+-ATPase from human erythrocytes.

Authors:  Claudia Colina; Vincenza Cervino; Gustavo Benaim
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

6.  A C-terminal, calmodulin-like regulatory domain from the plasma membrane Ca2+-pumping ATPase.

Authors:  P Brandt; M Zurini; R L Neve; R E Rhoads; T C Vanaman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

7.  Phosphatidylethanol stimulates the plasma-membrane calcium pump from human erythrocytes.

Authors:  M Suju; M Davila; G Poleo; R Docampo; G Benaim
Journal:  Biochem J       Date:  1996-08-01       Impact factor: 3.857

8.  Differential reactivity of lysine residues of the red blood cell Ca2+ pump involved in the E1-E2 conformational equilibrium.

Authors:  C Donnet; A J Caride; H N Fernández; J P Rossi
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

Review 9.  The Ca(2+)-transport ATPases from the plasma membrane.

Authors:  F Wuytack; L Raeymaekers
Journal:  J Bioenerg Biomembr       Date:  1992-06       Impact factor: 2.945

10.  A calmodulin-stimulated Ca2+ pump in plasma-membrane vesicles from Trypanosoma brucei; selective inhibition by pentamidine.

Authors:  G Benaim; C Lopez-Estraño; R Docampo; S N Moreno
Journal:  Biochem J       Date:  1993-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.